Cart 0

like-minded investors

Acceleris have a 20-year track record in supporting and advising early-stage companies. Investors benefit from high-quality early-stage investment opportunities that are advised throughout their lifecycle.

ADVISED OPPORTUNITIES

EACH OPPORTUNITY IS AN ADVISED CLIENT OF ACCELERIS CAPITAL

Acceleris Capital have 20 years experience in advising technology SMEs with a track record of delivering value. The senior team have deep experience in working with early stage ventures with over £120m introduced through EIS, over 100 transactions completed, 70 companies listed on AIM and multiple exit events for private companies.

FREE TO INVEST

THERE ARE NO FEES TO INVESTORS ON ANY INTRODUCED OPPORTUNITY

There are no fees to investors. All invested capital will go to the investee company and there is no carry on exit. We believe in complete transparency and alignment, ensuring ongoing communication between stakeholders and the company. Our fees are derived from the provision of genuine value add services for the lifecycle of the venture.

POWERFUL NETWORK

A COMMUNITY OF EXPERIENCE, INTELLIGENCE AND RESPECT

Our investor members pool their collective experience and support to our early-stage ventures. We all appreciate the risks, time-taken and hard-work needed to be successful. This community of partners can facilitate introductions and provide experience to our investees while our investors benefit from access to a powerful network of peers.

 

WHY ACCELERIS?

The Enterprise Investment Scheme was founded to accelerate the commercialisation of true UK innovation. Acceleris have always believed in this mission, have delivered market-leading results and provided significant positive impacts to society.

We believe that a combination of intelligent entrepreneurs, respectful risk-tolerant capital and world-class advisors reduces the risk of early-stage investment and leads to stronger, more valuable companies. By working together in a respectful way, by communicating transparently and by working hard, early-stage companies can thrive.

Acceleris are an FCA regulated advisory house committed to driving value and supporting early-stage technology. We are not brokers and ensure that each opportunity introduced to investors is one of our corporate advisory clients.

 

OPEN EIS OFFERS

Dpy6u6vXUAUXBgC.jpg
AdobeStock_85250554.jpg

VERTICAL FUTURE

Improving health in cities through a better, more sustainable food system.

Opportunity to invest in the immediate expansion of an established vertical farming business who boast 100+ b2b contracts across London. Through using smart agriculture technology to build high-tech farms in key urban areas of multiple deprivation, the company can bring fresh food closer to end-consumers. 

REACTA BIOTECH

Improving the quality of life for allergy sufferers

Commercialising the work of the world-leading authorities on allergy diagnostics. Reacta is now generating revenues in the US, UK & Canada and has recently located to an expanded manufacturing facility. Reacta is raising funds to expand and take advantage of its leading position on Oral Food Challenge diagnosis to support the effectiveness of allergy treatments.

Bite Club Kitchen

Scientifically driven nutrition and meal planning

Successfully launched manufacturing business specialising in scientifically supported nutrition. Opportunity to invest in the growth of the business as it expands to a chain of nationwide gyms and coffee shops. Embracing modern technology, the company intends to become the nations first nationwide meal planning service

AdobeStock_91503098.jpg

BIVICTRIX THERAPEUTICS

Working to eliminate toxicity in cancer therapeutics

Through direct experience in the NHS and with a leading Antibody Drug Conjugate ("ADC") sector specialist, the BiVictriX team has developed the Bi-Cygni platform. The platform is results in a marked increase in cancer target selectivity, addressing one of the key issues concerning the targeted oncology therapeutics industry.

 

ACCELERIS ACCEPT INVESTMENTS FROM CERTIFIED HIGH NET WORTH INDIVIDUALS, SOPHISTICATED, FAMILY OFFICER OR INSTITUTIONAL INVESTORS. ALL INVESTORS MUST APPLY TO ACCELERIS CAPITAL PRIOR TO RECEIVING FURTHER INFORMATION. YOUR CAPITAL IS AT RISK.